VJOncology is committed to improving our service to you

ESMO Breast 2020 | NSABP B-41: genes and signatures associated with pCR

VJOncology is committed to improving our service to you

Sandra Swain

Sandra Swain, MD, FACP, Georgetown University Medical Center, Washington, DC, discusses NSABP B-41, a randomized neoadjuvant trial using nanosting technology investigating the genes and signatures associated with pathologic complete response (pCR). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter